[P2] Poster Session 2 (Even Numbers)

[P-16] Characterization of an antibody that neutralizes a wide range of SARS-CoV-2 variants

^○Itsuki Anzai¹, Fujita Junso^2,3, Ono Chikako^1,4,5, Kosaka Yoichiro⁶, Miyamoto Yuki⁶, Shichinohe Shintaro¹, Takada Kosuke¹, Torii Shiho^1,4, Taguwa Shuhei^4,5, Suzuki Koichiro⁷, Makino Fumiaki^2,8, Kajita Tadahiro⁶, Inoue Tsuyoshi³, Namba Keiichi^2,9,10, Watanabe Tokiko^1,5, Matsuura Yoshiharu^1,4,5 (1.Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Japan, 2.Graduate School of Frontier Biosciences, Osaka University, Japan, 3.Graduate School of Pharmaceutical Sciences, Osaka University, Japan, 4.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Japan, 5.Center for Infectious Disease Education and Research (CiDER), Osaka University, Japan, 6.Bio Matrix Research, Inc., Japan, 7.The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Japan, 8.JEOL Ltd., Japan, 9.JEOL YOKOGUSHI Research Alliance Laboratories, Osaka University, Japan, 10.RIKEN Center for Biosystems Dynamics Research and Spring-8 Center, Japan)